United States reviews safety of electroconvulsive therapy

Benac, Nancy
March 2011
CMAJ: Canadian Medical Association Journal;3/22/2011, Vol. 183 Issue 5, pE269
Academic Journal
The article reports that the U.S. government will evaluate the safety of electroconvulsive therapy (ECT) as treatment for severe depression and other psychiatric disorders. It states that the assessment will identify whether ECT equipment should be categorized under Class III, the highest risk category for medical devices, or placed in a lesser-risk category. It says that the decision will be made by the U.S. Food and Drug Administration (FDA).


Related Articles

  • Czynniki przewidujÄ…ce skuteczność terapii elektrowstrzÄ…sowej. Studenna, Magdalena; Karakuła, Hanna; Flis, Marta // Current Problems of Psychiatry;2011, Vol. 12 Issue 4, p533 

    Electroconvulsive therapy (ECT) is the oldest method still used in psychiatric treatments. Due to small amount of randomized clinical trials there is little agreement about precise efficacy (most often determined in the range of 50-80%) and clinically useful predictors of acute ECT outcomes in...

  • Electroconvulsive Therapy in Sweden. Frederickesen, Svend-Otto; D'ella, Giacomo // British Journal of Psychiatry;Mar79, Vol. 134, p283 

    In spite of a decrease in the number of electroconvulsive treatments (ECT) administered during the decade 1966-1975, ECT is still commonly used in Sweden. About 4 per cent of all patients admitted for psychiatric treatment during 1975 received ECT. Affective disorders and confusional states...

  • The Sham ECT Literature: Implications for Consent to ECT. Ross, Colin A. // Ethical Human Psychology & Psychiatry;Spring2006, Vol. 8 Issue 1, p17 

    The author reviewed the placebo-controlled literature on electroconvulsive therapy (ECT) for depression. No study demonstrated a significant difference between real and placebo (sham) ECT at 1 month posttreatment. Many studies failed to find a difference between real and sham ECT even during the...

  • Bifrontal ECT: A Systematic Review and Meta-Analysis of Efficacy and Cognitive Impact. Plakiotis, Chris; O'Connor, Daniel W. // Current Psychiatry Reviews;2009, Vol. 5 Issue 3, p202 

    The aim of this paper is to review the literature regarding bifrontal electroconvulsive therapy (ECT) and provide recommendations for future research in this area. Original publications were retrieved using PubMeD, EMBASE, PsycINFO, and Google Scholar. A systematic review and meta-analysis of...

  • Historic and Other Treatments in Psychiatry. Peselow, Eric D.; Malavade, Kishor; Lowe, R. Sandlin; Glick, Ira // Primary Psychiatry;Dec2008, Vol. 15 Issue 12, p42 

    Throughout history numerous medications and unique treatments have been tried to diminish the frequency and severity of psychiatric symptoms. Some discovered by serendipity such as lithium, chlorpromazine, monoamine oxidase inhibitors, and tricyclic antidepressants, have been efficacious and...

  • Treatment of bipolar disorder: a systematic review of available data. Fountoulakis, Konstantinos; Vieta, Eduard; Kaprinis, George // Annals of General Psychiatry;2008 Supplement 1, Vol. 7, Special section p1 

    Background The current article is a systematic review of the data available concerning the treatment of bipolar disorder. Materials and methods A systematic MEDLINE search concerning treatment guidelines and clinical trials. Results The search for treatment guidelines returned 370 articles and...

  • Comparing the Effects of Repetitive Transcranial Magnetic Stimulation and Electroconvulsive Therapy in the Treatment of Depression: A Systematic Review and Meta-Analysis. Micallef-Trigona, Beppe // Depression Research & Treatment;2014, p1 

    Electroconvulsive therapy (ECT) is the longest standing psychiatric treatment available and has unequivocal benefit in severe depression. However this treatment comes with a number of side effects such as memory impairment. On the other hand, Repetitive Transcranial Magnetic Stimulation (rTMS)...

  • Misguided Thinking - Mental Health at a Crossroads. Areford, Chuck // Positive Health;Sep2010, Issue 174, p1 

    This article challenges some of the common practices in psychiatric treatment. According to the author, most psychiatric treatments appear to bring more harm than good to patients. Side effects associated with new anti-psychotic drugs are weight gain, diabetes and cardiovascular disease. A book...

  • The BB&T interview: Mark DuVal. STOMMEN, JIM // Biomedical Business & Technology;May2010, Vol. 33 Issue 5, p1 

    An interview with Mark DuVal, president of law firm DuVal & Associates, is presented. When asked about possible changes to the 510(k) program, he points out the lack of details provided by the U.S. Food and Drug Administration (FDA) on its review of the program. He expresses concern about plans...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics